17 February 2014

Walgreens Expands Access to Pharmacist-Led Hepatitis C Care as Treatments Advance

DEERFIELD, Ill., February 17, 2014 - With new advances in treatment therapy now available for hepatitis C patients, Walgreens (NYSE:WAG) (Nasdaq:WAG) today announced it is expanding access to Walgreens Connected Caresm hepatitis C program through its more than 100 hepatitis C-specialized pharmacies. Walgreens Connected Care is an education and support plan designed to help patients achieve a sustained virologic response (SVR) and improved quality of life through medication adherence.
12 February 2014

Walgreens Research Demonstrates Impact of Targeted Employer Prescription Programs on Improving Medication Adherence and Reducing Costs

DEERFIELD, Ill., February 12, 2014 - Walgreens (NYSE:WAG) (Nasdaq:WAG) today presented research on how value-based insurance design (VBID) programs can be optimized by targeting the sickest, least adherent and most costly patients. These findings, presented at the 2014 PBMI Drug Benefit Conference in Las Vegas, examined how the VBID model can be most successful by reaching these targeted employee sub-populations.

11 February 2014

Walgreens Collaborates with National Minority AIDS Council to Encourage African Americans with HIV to Get Recommended Vaccinations

DEERFIELD, Ill., February 11, 2014 - In collaboration with the National Minority AIDS Council (NMAC), Walgreens (NYSE: WAG) (Nasdaq: WAG) is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists’ training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.

15 January 2014

Walgreens Reaches Goal to Donate the Value of Three Million Life-Saving Vaccines in Developing Countries through United Nations Foundation’s Shot@Life Campaign

DEERFIELD, Ill., January 15, 2014 - Walgreens (NYSE: WAG) (Nasdaq: WAG) today announced it is donating the value of three million life-saving vaccines for children in developing countries, upon successful completion of its immunizations campaign developed in partnership with the UN Foundation’s Shot@Life campaign.

08 January 2014

Walgreens Outlines Growth Opportunities and Strategy at 2014 Annual Shareholders Meeting

DEERFIELD, Ill., January 08, 2014 - Reviewing a year of major strategic progress in transforming Walgreens (NYSE: WAG) (Nasdaq: WAG) for long-term sustainable growth and value creation, Chairman James A. Skinner, President and Chief Executive Officer Gregory D. Wasson and Executive Vice President, Chief Financial Officer and President, International Wade D. Miquelon today outlined the company’s growth opportunities and strategy at Walgreens Annual Shareholders Meeting. Addressing nearly 2,000 shareholders in Chicago, company leadership also discussed the substantial progress Walgreens has made since announcing its “plan to win” in 2009.
30 December 2013

Walgreens to Provide Up to 30-Day Prescription Supply at No Upfront Cost for Public Health Insurance Marketplace Enrollees Who Have Not Been Assigned an Identification Number

DEERFIELD, Ill., Dec. 30, 2013 – As newly insured Americans begin using their benefits under the Affordable Care Act, Walgreens (NYSE: WAG) (Nasdaq: WAG) will provide medications to those patients who may have difficulty using their new insurance coverage because they haven't received a plan identification number yet from their insurer. In those situations, through the end of January, patients can bring confirmation of their enrollment in the public health insurance marketplace to a Walgreens pharmacy, or the pharmacy staff can check to verify eligibility, and Walgreens will assist them by providing up to a month of a traditional, brand and generic medication at no upfront cost.
26 December 2013

Walgreens Earns Top Marks in 2014 Corporate Equality Index

 DEERFIELD, Ill., December 26, 2013 - Walgreens (NYSE: WAG) (Nasdaq: WAG) received a perfect score of 100 percent on the 2014 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation. This marks the eighth year Walgreens has earned a perfect score from the CEI index.
16 December 2013

Walgreens Announces Collaboration with Centers for Disease Control and Prevention to Improve HIV Prevention and Outcomes

DEERFIELD, Ill., December 16, 2013 - In support of the more than 1.1 million people living with HIV in the U.S., Walgreens (NYSE: WAG) (Nasdaq: WAG) is collaborating with the Centers for Disease Control and Prevention (CDC) to develop and evaluate a model of HIV patient-centered care through a national project aimed at advancing clinical integration and medication therapy management. The program is another way Walgreens is extending its commitment to improve HIV prevention and treatment outcomes.

22 November 2013

Johns Hopkins Medicine and Walgreens Expand Health Care Collaboration with Opening of New Store, Bringing Health and Wellness Services to Campus Community

DEERFIELD, Ill. & BALTIMORE, November 22, 2013 - Officials from Walgreens (NYSE: WAG) (Nasdaq: WAG) and Johns Hopkins Medicine (JHM) today celebrate the expansion of a unique collaboration between the two parties, with the grand opening of a new Walgreens store adjacent to the JHM campus. The store project is a joint effort to bring new health and wellness programs and other health care services to the surrounding community, furthering the partnership between Johns Hopkins and Walgreens to explore the development of new models for improving overall patient care.